Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neuroendocrine Tumor Grade 2 × NET × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 18 von Hippel-Lindau Disease 1 Recurrence 1 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumor Grade 2 1 Neuroblastoma 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1 Adenoma, Islet Cell 1

Interventions

Single Photon Emission Computed Tomography Computed Tomography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05111509 2025-07-14

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

University of Iowa

Phase EARLY_PHASE1 Active not recruiting

Neuroendocrine Tumor Grade 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡